The Biology of Depression in Children and Adolescents

  • Neal D. Ryan
  • Ronald E. Dahl
Part of the The Depressive Illness Series book series (DISS, volume 4)

Abstract

Until the last two decades, it was assumed that children did not experience adult forms of depression. This was based on etiologic hypotheses of depression which required cognitive maturity beyond that possessed by children. Thus, it was suggested that children might have variant forms of depression, so called “masked depression,” which were symptomatologically unlike adult depression but which might evolve into adult forms of the disorder. It was thought that the adult pattern was just not seen in this younger age group.

Keywords

Growth Hormone Major Depressive Disorder Growth Hormone Secretion Growth Hormone Response Growth Hormone Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amsterdam JD, Maislin G, Winokur A, Kling M, Gold P: Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. Arch Gen Psychiatry 1987; 44 (9): 775–781.PubMedCrossRefGoogle Scholar
  2. Ansseau M, Scheyvaerts M, Doumont A, Poirrier R, Legros JJ, Franck G: Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiat Res 1984; 12: 261–272.CrossRefGoogle Scholar
  3. Appleboom-Fondu J, Kerkhofs M, Mendlewicz J: Depression in adolescents and young adults: Polysomnographic and neuroendocrine aspects. J Affec Disord 1988; 14: 35–40.Google Scholar
  4. Beck-Friis J, Von Rosen D, Kjellman BF, Ljunggren J, and Wetterberg L: Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorder and healthy subjects. Psychoneuroendocrinology 1984; 9: 261–277.PubMedCrossRefGoogle Scholar
  5. Birmaher B, Ryan ND, Dahl RE, Rabinovich H, Ambrosini P, Williamson DE, Novacenko H, Nelson B, Sing Lo E, Puig-Antich J: Dexamethasone suppression test in children with major depressive disorder. J Am Acad Child Adolescent Psychiatry 1992; 31: 291–297.CrossRefGoogle Scholar
  6. Birmaher B, Puig-Antich J, Dahl RE, Ryan ND, Williamson DE, Rabinovich H, Ambrosini P, Novacenko H: Dexamethasone suppression test in childrenGoogle Scholar
  7. and adolescents. It is clinical relevant? Presented at AACAP in Chicago (1990).Google Scholar
  8. Bramibilla F, Musetti C, Tacchini C, Fontanilla S, Guareshi-Cazzulo A: Neuroendocrine investigation in children and adolescents with dythymic disorder: The DST, TRH, and clonadine test. J Affec Dis 1989; 17: 279–284.CrossRefGoogle Scholar
  9. Brent DA, Perper JA, Allman CJ: Alcohol, firearms, and suicide among youth. Temporal trends in Allegheny County, PA, 1960–1983. J Am Med Assoc 1987; 257: 3369–3372.CrossRefGoogle Scholar
  10. Brown R, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes PE, Frazer A: Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 1985; 142: 811–816.PubMedGoogle Scholar
  11. Carstens ME, Englebrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJF: Alphas-adrenoceptor levels on platelets of patients with major depressive disorder. Psychiat Res 1986a; 18: 321.CrossRefGoogle Scholar
  12. Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Taljaard JJF: Imipramine binding sites on platelets with major depressive disorder. Psychiat Res 1986b; 18: 333.CrossRefGoogle Scholar
  13. Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJF: B-Adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiat Res 1987; 20: 239.CrossRefGoogle Scholar
  14. Carstens ME, Engelbrecht AH, Russell VA, van Zyl AM, Taljaard JJF: Biological markers in juvenile depression. Psychiat Res 1988; 23: 77–88.CrossRefGoogle Scholar
  15. Cavallo A, Holt KG, Masoud S, Hejazi S, Richards GE, Meyer WJ: Melatonin circadian rhythm in childhood depression. J Am Acad Child Adolescent Psychiatry 1987; 26: 395–399.CrossRefGoogle Scholar
  16. Checkley SA, Slade AP, Shur E: Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 1981; 138: 51–55.PubMedCrossRefGoogle Scholar
  17. Claustrat B, Chazot G, Grun J, Jordon D, Sassolas G: A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984; 19: 1215–1228.PubMedGoogle Scholar
  18. Dahl RE, Ryan ND, Birmaher B, Al-Shabbout M, Williamson DE, Neidig M, Nelson B, Puig-Antich J: EEG sleep measures in prepubertal depression. Psychiat Res 1991; 38: 201–214.CrossRefGoogle Scholar
  19. Dahl RE, Ryan ND, Williamson DE, Ambrosini PJ, Rabinovich H, Novacenko H, Nelson B, Puig-Antich J: The regulation of sleep and growth hormone in adolescent depression. J Am Acad Child Adolescent Psychiatry 1992; 31: 615–621.CrossRefGoogle Scholar
  20. Dahl RE, Puig-Antich J, Ryan ND, Nelson B, Novacenko H, Twomey J, Williamson D, Goetz R, Ambrosini PJ: Cortisol secretion in adolescents with major depressive disorder. Acta Psychiat Scand 1989; 80: 18–26.PubMedCrossRefGoogle Scholar
  21. Dahl RE, Puig-Antich J, Ryan N, Nelson B, Dachille S, Cunningham S, Trubnick L, Klepper T: EEG sleep in adolescents with major depression: The role of suicidality and inpatient status. J Affect Disord 1990; 19: 63–75.PubMedCrossRefGoogle Scholar
  22. Dahl RE, Ryan ND, Puig-Antich J, Birmaher B, Meyer V, Nguyen N: BaselineGoogle Scholar
  23. cortisol secretory patterns in normal and depressed children and adolescents. Presented at Chicago AACAP, 1990.Google Scholar
  24. Dahl RE, Ryan ND, Puig-Antich J, Nguyen N, Al-Shabbout M, Meyer V, Perel J: 24-hour cortisol measures in adolescents with major depression: A controlled study. Biological Psychiatry 1991; 22: 91–100.Google Scholar
  25. Dahl RE, Siegel SF, Williamson DE, Lee PA, Perel J, Birmaher B, Ryan ND: CRH stimulation test and nocturnal cortisol levels in normal children. 1992; 3 (1): 64–68.Google Scholar
  26. Daughaday W: Growth hormone: Normal synthesis, secretion, control, and mechanisms of action. In: DeGroot L.J. (Ed.), Endocrinology, Philadelphia: W.B. Saunders, 1989, Vol II, 318–328.Google Scholar
  27. Doherty M, Madansky D, Kraft J, Carter-Ake L, Rosenthal P, Coughlin B: Cortisol dynamics and test performance of the dexamethasone suppression test in 97 psychiatrically hospitalized children aged 3–16 years. J Am Acad Child Psychiatry 1986; 25: 400–408.CrossRefGoogle Scholar
  28. Emslie GJ, Rush AJ, Weinberg WA, Rintelmann JW, Roffwarg HP: Children with major depression show reduced rapid eye movement latencies. Arch Gen Psychiatry 1990; 47: 119–124.PubMedCrossRefGoogle Scholar
  29. Emslie G, Weinberg W, Rush AJ, Weissenburger J, Parkin-Feigenbaum L: Depression and dexamethasone suppression testing in children and adolescents. J Child Neurol 1987; 2: 31–37.PubMedCrossRefGoogle Scholar
  30. Eriksson E, Balldin J, Linstedt G, Modigh K: Growth hormone responses to the alpha2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls. Psychiat Res 1988; 26: 59–67.CrossRefGoogle Scholar
  31. Evans D, Nemeroff C, Haggerty J, Perdersen C: Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents. Psychoneuroendocrinology 1987; 12: 203–209.PubMedCrossRefGoogle Scholar
  32. Extein I, Rosenberg G, Pottash A, Gold M: The dexamethasone suppression test in depressed adolescents. Am J Psychiatry 1982; 139: 1617–1619.PubMedGoogle Scholar
  33. Fristad M, Weller R, Teare M, Preskorn S: Self report vs. biological markers in assessment of childhood depression. J Affect Disord 1989; 15: 339–345.CrossRefGoogle Scholar
  34. Fleming JE, Offord DR: Epidemiology of childhood depressive disorders: A critical review. J Am Acad Child Adolescent Psychiatry 1990; 29: 571–580.CrossRefGoogle Scholar
  35. Freeman L, Pozanski E, Grossman J, Buchsbaum Y, Banegas M: Psychotic and depressed children: A new entity. J Am Acad Child Psychiat 1985; 24: 195–202.Google Scholar
  36. Geller B, Cooper TB, McCombs HG, Graham D, Wells J: Double-blind, placebo-controlled study of nortiptyline in depressed children using a “fixed plasma level” design. Psychopharmacol Bull 1989; 25: 101–108.PubMedGoogle Scholar
  37. Geller B, Rogol A, Knitter E: Preliminary data on the dexamethasone suppression test in children with major depressive disorder. Am J Psychiatry 1983; 140: 620–622.PubMedGoogle Scholar
  38. Goetz RR, Puig-Antich J, Ryan ND, Rabinovich H, Ambrosini J, Nelson B, Krawiec V: The EEG sleep of adolescents with major depressive and normal controls. Arch Gen Psychiatry 1987; 44: 61–68.PubMedCrossRefGoogle Scholar
  39. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic and diagnostic implications. N Engl J Med 1986; 314 (21): 1329–1335.PubMedCrossRefGoogle Scholar
  40. Gold PW, Goodwin FK, Chrousos GP: Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress. N Eng J Med 1988; 319: 348–353.CrossRefGoogle Scholar
  41. Ha H, Kaplan S, Foley C: The dexamethasone suppression test in adolescent psychiatric patients. Am J Psychiatry 1984; 141: 421–423.PubMedGoogle Scholar
  42. Hawkins DR, Taub JM, Van de Castle RL: REM latency: Extended sleep (hyper- somnia) in young depressed patients. Am J Psychiatry 1985; 142: 905–910.PubMedGoogle Scholar
  43. Harrington R, Fudge H, Rutter M, Pickles A, Hill J: Adult outcomes of childhood and adolescent depression. I. Psychiatric status. Arch Gen Psychiatry 1990; 47: 465–473.PubMedCrossRefGoogle Scholar
  44. Holsboer F, Gerken A, Stalla GK: Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am J Psychiatry 1987; 144 (2): 229–231.PubMedGoogle Scholar
  45. Jarrett DB, Miewald JM, Kupfer DJ: Recurrent depression as associated with a persistent reduction in sleep-related growth hormone secretion. Arch Gen Psychiatry 1990; 47: 113–118.PubMedCrossRefGoogle Scholar
  46. Jensen JB, Garfinkel BD: Growth hormone dysregulation in children with major depressive disorder. J Am Acad Child Adolescent Psychiatry 1990; 29: 295–301.CrossRefGoogle Scholar
  47. Khan A: Biochemical profile of depressed adolescents. J Am Acad Child Adolescent Psychiatry 1987; 26: 873–878.CrossRefGoogle Scholar
  48. Klee S, Garfinkel B: Identification of depression in children and adolescents: The role of dexamethasone suppression test. J Am Acad Child Psychiatry 1984; 23: 410–415.PubMedCrossRefGoogle Scholar
  49. Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R: Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 1984a; 41: 229–237.PubMedCrossRefGoogle Scholar
  50. Kovacs M, Feinberg TL, Crouse-Novack M, Paulauskas SL, Pollock M, Finkelstein R: Depressive disorders in childhood. II. A longitudinal study of the risk of a subsequent major depression. Arch Gen Psychiatry 1984b; 41: 643–649.PubMedCrossRefGoogle Scholar
  51. Kraeplin E: In: Barclay RM, trans., Robertson GM, ed., Manic—Depressive Insanity and Paranoia. Edinburgh: EandS Livingstone; 1921.Google Scholar
  52. Kutcher S: Child Depression Consortium Meeting. Pittsburgh, Pennsylvania, 1990.Google Scholar
  53. Kutcher SP, Williamson P, Silverberg J, Marton P, Malkin D, Malkin A: Nocturnal growth hormone secretion in depressed older adolescents. J Am Acad Child Adolescent Psychiatry 1988; 27: 751–754.CrossRefGoogle Scholar
  54. Lahmeyer HW, Poznanski EO, Bellur SN: EEG sleep in depressed adolescents. Am J Psychiatry 1983; 140 (9): 1150–1153.PubMedGoogle Scholar
  55. Lesch K-P, Laux G, Erb A, Pfuller H, Beckmann H: Growth hormone (GH) responses to GH-releasing hormone in depression: Correlation with GH release following clonidine. Psychiat Res 1988; 25: 301–310.CrossRefGoogle Scholar
  56. Lewy AJ: Biochemistry and regulation of mammalian melatonin production. In: Relkin R. (Ed.), The Pineal Gland, New York: Elsevier Biomedical, 1983, 77–128.Google Scholar
  57. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Rosenthal NE: Manic—depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384.PubMedCrossRefGoogle Scholar
  58. Livingston R, Reis C, Ringkahl I: Abnormal dexamethasone suppression test results in depressed and nondepressed children. Am J Psychiatry 1984; 141: 106–108.PubMedGoogle Scholar
  59. Livingston R, Martin-Cannici C: Depression, anxiety and the dexamethasone suppression test in hospitalized prepubertal children. Hillside J Clin Psychiatry 1987; 9: 55–63.PubMedGoogle Scholar
  60. Lopez-Ibor JJ, Saiz-Ruiz J, Iglesias LM: Neuroendocrine challenges in the diag- nosis of depressive disorders. Br J Psychiatry 1989; 154 (suppl 4): 73–76.Google Scholar
  61. Matussek N, Ackenheil M, Hippius H, Muller F, Schroder H-Th, Schultes H, Wasilewski B: Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiat Res 1980; 2: 25–36.CrossRefGoogle Scholar
  62. Meltzer H, Arora RC, Baber R, Tricov BJ: Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 1981; 38: 1322–1326.PubMedCrossRefGoogle Scholar
  63. Mendlewicz J, Linkowski P, Kerhofs M, Desmedt D, Golstein J, Copinschi G, Van Cauter E: Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metabolism 1985; 60: 505–512.CrossRefGoogle Scholar
  64. Meyer WJ III, Richards GE, Cavallo A, Holt KG, Hejazi MS, Wigg C, Rose RM: Depression and growth hormone. J Am Acad Child Adolescent Psychiatry 1991; 30: 335.CrossRefGoogle Scholar
  65. Mitchell BP, Beam JA, Corn TH, Checkley SA: Growth hormone response to clonidine after recovery in patients with endogenous depression. Br J Psychiatry 1988; 152: 34–38.PubMedCrossRefGoogle Scholar
  66. Modai I, Zemishlany Z, Jerushalmy Z: 5HT uptake by blood platelets of unipolar and bipolar depressed patients. Neuropsychobiology 1984; 12: 93–95.PubMedCrossRefGoogle Scholar
  67. Modai I, Apter A, Meltzer M, Tyano S, Walevski A, Jerushalmy Z: Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatients. Neuropsychobiology 1989; 21: 9–13.PubMedCrossRefGoogle Scholar
  68. Naylor M, Greden J, Alessi N: Plasma dexamethasone levels in children given the dexamethasone suppression test. Biol Psychiatry 1990; 27: 592–600.PubMedCrossRefGoogle Scholar
  69. Neuhauser H, Laakmann G: Stimulation of growth hormone by GHRH as com- pared to DMI depressed patients. Pharmacopsychiatry 1988; 21: 443–444.PubMedCrossRefGoogle Scholar
  70. Nurnberger JI Jr, Berrettini W, Tamarkin L, Hamovit J, Norton J, Gershon E: Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. Neuropsychopharmacology 1988; 1: 217–223.PubMedCrossRefGoogle Scholar
  71. Petty L, Asarnow J, Carlson G, Lesser L: The dexamethasone suppression test in depressed, dysthymic, and nondepressed children. Am J Psychiatry 1985; 142: 631–633.PubMedGoogle Scholar
  72. Pfeffer C, Stokes P, Weiner A, Shindledecker R, Faughnan L, Mintz M, Stoll P, Heiligenstein E: Psychopathology and plasma cortisol responses to dexamethasone in prepubertal inpatients. Biol Psychiatry 1989; 26: 677–689.PubMedCrossRefGoogle Scholar
  73. Pfeffer C, Stokes P, Shindledecker R: Suicidal behavior and hypothalamicpituitary-adrenocortical axis indices in child psychiatric inpatients. Biological Psychiatry 1991; 29: 909–917.PubMedCrossRefGoogle Scholar
  74. Pfohl B, Sherman B, Schlect J, Stone R: Pituitary-adrenal axis rhythm distur- bances in psychiatric depression. Arch Gen Psychiatry 1985; 42: 897–903.PubMedCrossRefGoogle Scholar
  75. Pozanski E, Carroll B, Banegas M, Cook S, Grossman J: The dexamethasone suppression test in prepubertal depressed children. Am J Psychiatry 1982; 139: 321–324.Google Scholar
  76. Preskorn SH, Weller EB, Weller RA: Depression in children: Relationship between plasma imipramine levels and response. J Clin Psychiatry 1982; 43: 450–453.PubMedGoogle Scholar
  77. Preskorn SH, Weller EB, Weller RA, Glotzbach E: Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 1983; 140: 1332–1335.PubMedGoogle Scholar
  78. Preskorn SH, Weller EB, Hughes CW, Weller RA, Bolter K: Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo. Psychopharmacol Bull 1987; 23: 128–133.PubMedGoogle Scholar
  79. Puig-Antich J, Chambers W, Halpern W, Hanlon C, Sachar EJ: Cortisol hyper-secretion in prepubertal major depressive illness: A preliminary report. Psychoneuroendocrinology 1979; 4: 191–197.PubMedCrossRefGoogle Scholar
  80. Novacenko H, Davies M, Tabrizi MA, Ambrosini P, Goetz R, Bianca J, Goetz D, Sachar EJ: Growth hormone secretion in prepubertal children with major depression. I. Final report on response to insulin-induced hypoglycemia during a depressive episode. Arch Gen Psychiatry 1984a; 41: 455–460.PubMedCrossRefGoogle Scholar
  81. Puig-Antich J, Goetz R, Davies M, Fein M, Hanlon C, Chambers WJ, Tabrizi MA, Sachar EJ, Weitzman ED: Growth hormone secretion in prepubertal major depressive children. II. Sleep related plasma concentrations during a depressive episode. Arch Gen Psychiatry 1984b; 41: 463–466.PubMedCrossRefGoogle Scholar
  82. Puig-Antich J, Novacenko H, Davies M, Tabrizi MA, Ambrosini P, Goetz R, Bianca J, Goetz D, Sachar EJ: Growth hormone secretion in prepubertal children with major depression. III. Response to insulin-induced hypoglycemia after recovery from a depressive episode and a drug-free state. Arch Gen Psychiatry 1984c; 41: 471–475.PubMedCrossRefGoogle Scholar
  83. Puig-Antich J, Goetz R, Davies M, Tabrizi MA, Novacenko H, Hanlon C, Sachar EJ, Weitzman ED: Growth hormone secretion in prepubertal major depressive children. IV. Sleep related plasma concentrations in a drug-free fully recovered clinical state. Arch Gen Psychiatry 1984d; 41: 479–483.PubMedCrossRefGoogle Scholar
  84. Puig-Antich J, Lukens E, Davies M, Goetz D, Brennan-Quattrock J, Todak G: Psychosocial functioning in prepubertal major depressive disorders. I: Interpersonal relationship during the depressive episode. Arch Gen Psychiatry 1985; 42: 500–507.PubMedCrossRefGoogle Scholar
  85. Puig-Antich J, Goetz R, Davies M, Kaplan T, Davies S, Ostrow L, Asnis L, Twomey J, Iyengar S, Ryan ND: A controlled family history study of prepubertal major depressive disorders. Arch Gen Psychiatry 1989; 46: 406–418.PubMedCrossRefGoogle Scholar
  86. Puig-Antich J, Dahl RE, Ryan ND, Novacenko H, Goetz D, Goetz R, Twomey J, Klepper T: Cortisol secretion in prepubertal children with major depressive disorder. Arch Gen Psychiatry 1989; 46: 801–809.PubMedCrossRefGoogle Scholar
  87. Rapoport JL, Buchsbaum MS, Weingarner H: Dextroamphetamine: Its cognitive and behavioral effects in hyperactive boys and normal men. Arch Gen Psychiatry 1980; 47: 933–943.CrossRefGoogle Scholar
  88. Reynolds CF, Kupfer DJ: Sleep research in affective illness: State of the art circa 1987 (State-of-the-art review). Sleep 1987; 10: 199–215.PubMedGoogle Scholar
  89. Robbins D, Alessi N, Yanchyshyn G, Colfer M: Preliminary report on the dexamethasone suppression test in adolescents. Am J Psychiatry 1982; 22: 467–469.Google Scholar
  90. Robbins D, Alessi N, Yanchyshyn G, Golfer M: The dexamethasone suppression test in psychiatrically hospitalized adolescents. J Am Acad Child Adolescent Psychiatry 1983; 22: 467–469.CrossRefGoogle Scholar
  91. Robbins D, Alessi N: Suicide and the dexamethasone suppression test in adolescence. Biol Psychiatry 1985; 20: 107–110.PubMedCrossRefGoogle Scholar
  92. Rogeness GA, Mitchell EL, Custer GJ, Harris WR: Comparison of whole blood serotonin and platelet MAO in children with schizophrenia and major depressive disorder. Biol Psychiatry 1985; 20: 270–275.PubMedCrossRefGoogle Scholar
  93. Ryan ND: Psychoneuroendocrinology of childhood depression and autism. Presentation at the XXII Congress of the International Society of Psychoneuroendocrinology, Siena, Italy, 1991. Ryan ND: Child Depression Consortium Meeting. Pittsburgh, Pennsylvania, 1990.Google Scholar
  94. Ryan ND, Puig-Antich J, Cooper TB, Rabinovich H, Ambrosini P, Davies J, King J, Torres D, Fried J: Imipramine in adolescent major depression: Plasma level and clinical response. Acta Psychiatr Scand 1986; 73: 275–288.PubMedCrossRefGoogle Scholar
  95. Ryan ND, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, Iyengar S, Twomey J: The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 1987; 44: 854–861.PubMedCrossRefGoogle Scholar
  96. Ryan ND, Meyer V, Dachille S, Mazzie D, Puig-Antich J: Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolescent Psychiatry 1988; 27: 371–376.CrossRefGoogle Scholar
  97. Ryan ND, Puig-Antich J, Rabinovich H, Ambrosini P, Robinson D, Nelson B, Novacenko H: Growth hormone response to desmethylimipramine in depressed and suicidal adolescents. J Affective Disord 1988; 15: 323–337.CrossRefGoogle Scholar
  98. Ryan ND, Puig-Antich J, Rabinovich H, Fried J, Ambrosini P, Meyer V, Torres D, Dachille S, Mazzie D: MAOIs in adolescent major depression unresponsive to tricyclic antidepressant. J Am Acad Child Adolescent Psychiatry 1988; 27: 755–758.CrossRefGoogle Scholar
  99. Ryan ND, Williamson DE, Iyengar S, Orvaschel H, Reich T, Dahl RE, PuigAntich J: A secular increase in child and adolescent onset affective disorder. J Am Acad Child Adolescent Psychiatry 1992; 31: 600–605.CrossRefGoogle Scholar
  100. Steingard R, Biederman J, Keenan K, Moore C: Comorbidity in the interpretation of the dexamethsone suppression test results in children: A review and report. Biol Psychiatry 1990; 28: 193–202.PubMedCrossRefGoogle Scholar
  101. Strober M, Carlson G: Bipolar illness in adolescents with major depression: Clinical, genetic and psychopharmacologic predictors in a three-to-fouryear follow-up investigation. Arch Gen Psychiatry 1982; 39: 549–555. Google Scholar
  102. Strober M, Morrell W, Burroughs J, Lampert C, Danforth H, Freeman R: A family study of bipolar I disorder in adolescence: Early onset of symptoms linked to increased familial loading and lithium resistance. J Affective Disord 1988; 15: 255–268.Google Scholar
  103. Strober M, Freeman R, Rigali J: The pharmacotherapy of depressive illness in adolescence. Psychopharmacol Bull 1990; 26: 80–84.Google Scholar
  104. Targum S, Capodanno A: The dexamethasone suppression test in adolescent psychiatric inpatients. Am J Psychiatry 1983; 140: 589–591.Google Scholar
  105. Tuomisto J, Tukiainen E, Ahlfors VG: Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 1979; 65: 141–147.Google Scholar
  106. Uhde TW, Vittone BJ, Siever LJ, Kaye WH, Post RM: Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 1986; 21: 1081–1085.Google Scholar
  107. Weissman MM, Gammon GD, John K, Merikangas KR, Warner V, Prusoff BA, Sholoomskas D: Children of depressed parents: Increased psychopathology and early onset of major depression. Arch Gen Psychiatry 1987; 44: 847–853.Google Scholar
  108. Weller E, Weller R, Fristad M, Preskorn S: The dexamethasone suppression test in hospitalized prepubertal children. Am J Psychiatry 1984; 141: 290–291. Google Scholar
  109. Weller E, Weller R, Fristad M, Preskorn S, Teare M: The dexamethasone suppression test in hospitalized prepubertal children. J Clin Psychiatry 1985; 46: 511–513.Google Scholar
  110. Williamson DE, Dahl RE, Ryan ND: Subjective sleep disturbances in children and adolescents with major depressive disorder. Sleep Res 1991; 20: 193. Google Scholar
  111. Woodside B, Brownstone D, Fisman S: The dexamethasone suppression test and the Children’s depression inventory in psychiatric disorders in children. Can J Psychiatry 1987; 32: 2–4.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Neal D. Ryan
    • 1
  • Ronald E. Dahl
    • 1
  1. 1.Division of Child and Adolescent PsychiatryUniversity of Pittsburgh, School of MedicinePittsburghUSA

Personalised recommendations